Hani Choudhry

We are a research group working at the interface of chemistry and biology to design probes and inhibitors to investigate the intricate workings of human proteins and cells, with particular interest in epigenetics and dementia. We form part of the Alzheimer's Research UK Oxford Drug Discovery Institute (ODDI) at the University of Oxford.

is an Assistant Professor of Oncology in the Biochemistry Department at King Abdulaziz University (KAU).

She is currently the head of Evaluation and Assessment Unit at the Quality and Academic Accreditation Deanship at KAU. Furthermore, Dr Albukhari is a member in different research units including the Cancer and Mutagenesis unit and the Experimental Biochemistry unit at King Fahd Medical Research Center. She is also a principal investigator of a collaborative project with University of Oxford and a member of other ongoing research projects in addition to supervising postgraduate students at KAU.

Dr Albukhari obtained her BSc and MSc in Biochemistry from King Abdulaziz University and her DPhil in Oncology from University of Oxford. She has experience in cancer biology and genomics. Additionally, she has experience in developing in vitro pre-clinical models for cancer research as well as in vivo work using animal models. Her current research focuses on understanding the origin of ovarian cancer and identifying novel biomarkers for its early detection. Furthermore, she is interested in investigating the molecular mechanisms underlying the response and resistant to cancer therapies using several genomic and biochemical approaches.

Translational Scientist

Cassandra Adams is a translational scientist in the Centre for Medicines Discovery. She received her D.Phil. in Clinical Laboratory Sciences at the University of Oxford in 2010 under the supervision of Prof. Nick La Thangue. She then undertook post-doctoral research on radiation-induced tumorigenesis in the laboratory of Prof. Allan Balmain at the University of California, San Francisco (UCSF). During which time she was awarded a full fellowship from the Leukemia and Lymphoma Society. Subsequently she became a senior staff scientist in Genome Analysis Core Facility, UCSF where she launched and managed the new Single Cell Analysis Center.

Cassandra joined the BRC team in 2018 as a translational scientist and is currently working on a range of projects accelerating novel drug targets downstream in a variety of therapeutic areas; including rare disease, oncology and inflammatory disease.

Dr. Wesam Abdulaal has a PhD in Biochemistry from Faculty of life Science from University of Manchester, United Kingdom since 2015 and has Master of Science in Analytical Bioscience from University of Huddersffield United Kingdom since 2011. His Bachelor degree was from Abdul Aziz University since 2004. Currently, Dr. Abdulaal is an associate professor in Biochemistry in Faculty of life Science, department of biochemistry, King Abdul-Aziz University, Saudi Arabia. Dr. Abdulaal is also head of the central labs part of the Research And Consulting Institute, in KAU

Dr. Abdulaal researches interests are cytokine network and its role in the inflammation, gut inflammation and T cells immune response and generation and use complete or conditional knockout mice for different cytokine in order to investigate its role in response to infection or diseases.

I am an Associate Professor of the Department of Psychiatry and the Big Data Institute, and part of Dementia Research Oxford. I am very glad to supervise the AI team in the TNDR, formed by 10 excellent machine learners and bioinformaticians. Our focus is on the applications of machine learning and bioinformatics to mental health care. In addition, I also hold a position at the Big Data Institute, where we collaborate in the application of machine learning to genomics and target discovery. I am also consultant to a number of AI companies.

MBBS-MD, MSc, PhD, FHEA

Dr Majid is a physician scientist and an assistant professor in the Clinical Biochemistry Department, Faculty of Medicine. Dr Majid studied molecular medicine and obtained both MSc and PhD degrees in this field from the University of Sheffield, UK. In addition to his molecular medicine speciality, Dr Majid also brings tremendous experience in the blockchain technology. He served multiple advisory and consultancy roles for national and international blockchain companies and led the development of projects in this area. His expertise in both medical research and emerging technologies allows him to leverage skills from both domains and empower digital transformation driven medical research.

Cornelia M van Duijn is Professor of Epidemiology at NDPH and Fellow of St Cross College, Oxford. She studied Human Nutrition and Mathematical Statistics at the Agricultural University of Wageningen and Genetics and Epidemiology at the Erasmus University Medical School.

Her research within the Oxford Big Data Institute focuses on large-scale –omics studies of neurodegenerative disorders including Alzheimer, Parkinson and Creutzfeldt–Jakob disease and ophthalmological disorders including glaucoma, age related macular degeneration and myopia. She further studies systemic vascular, endocrine and gastrointestinal pathology that is relevant for brain and ocular function. Her current research portfolio includes cross-omics research integrating (epi)genetic, transcriptomic, proteomic, metabolomic and microbiome data of epidemiological cohorts with state of the art brain imaging and cellular model systems.

Dr Mazin Zamzami is an Associate Professor at the Biochemistry Department in the Faculty of Science at King Abdulaziz University. Dr Zamzmi is the vice dean for development at the faculty of science and formerly the chairman of the Biochemistry Department. He joined King Abdulaziz University in 2002 as a lecturer in Biochemistry at the Faculty of Health Sciences, and granted his PhD in Clinical Biochemistry from the University of Queensland, Brisbane, Australia in 2012. Dr Zamzami has a clinical research interest in the molecular basis of disease, particularly nucleotide metabolic diseases, and pharmacogenomics. He also involved in international collaborative projects with Australia, the USA and UK. Recently he established a clinical research group for nucleotide metabolic diseases and diagnostics, biochemistry department. Dr Zamzami published several articles on non-canonical nucleotides effects on mitochondria, as well as targeting cancer treatment with natural products and he presented them at international and national scientific conferences, and he has continued his contribution to research in metabolic diseases. Dr Zamzami worked recently with his team to invent a biosensor and point of care like device for detecting the thiopurin s-methyltransferase (TPMT) activity before the leukemic patient treatment began. The invention now is under filing process in the United States patent and trademark office, from Jul 2019 (Application no. 513847US), and the biosensors are at the validation stage.

Research interests

• Protein structure
• Immunoinformatics
• Biological networks
• Small Molecules

Research in the Oxford Protein Informatics Group covers several areas in protein structure and interaction networks, combining both theoretical with and empirical analysis.

I am proudly an academic member at King Abdulaziz University - Faculty of science - Biochemistry department, and I am currently the head of my department. I have several experiences in academic and administrative work - mainly within the university - such as working on academic accreditations, educational laboratory management, and also coordinating projects between our department and the private sector. Furthermore, teaching and mentoring undergraduate and postgraduate students is an ongoing activity that I always enjoy.

I am the head of the innovation and knowledge economy unit at the Knowledge economy and technology transfer center (KETT) at KAU, where promoting the culture of innovation and creativity among the university members is my main job, and teaching innovators how to protect their products through intellectual property laws. I am also a member of the Technology and Innovation Support Centers (TISC) recognized by WIPO at KAU.

My scientific specialty is in molecular biology - insulin signaling and insulin resistance (cell signaling), kidney disease (nephrology), diabetes, proteomics, and different aspects of the field. The tools that I use in my work are molecular biology techniques, mass spectrometry, and bioinformatics (proteomics).

I am open to collaboration opportunities, and If you are near or around KAU, drop by the biochemistry department and we will be happy to talk to you.

Assistant Professor at Computing and Technology Collage – Vice Dean for Development at e-Learning Deanship – Director for High performance computing (HPC) center – King Abdul-Aziz University

He received his graduate degrees from United States of America (USA) from Engineering School - George Mason University. A Ph.D in smart cyber security, two Master degrees in Information Technology and Information System, and two graduate certificate degrees in Information Security and e-commerce.

He is Supervising the AI program, that offering an AI curriculum for all undergraduate program in KAU. Also, participating on smart e-learning research team on KAU that focus on the usability of the massive e-learning data that include the learning styles, students’ behavior, and measurable learning outcome on building smart e-learning system.

In addition, he is Supporting AI research groups to recognize the benefit of the high-performance computer system on speeding up the data processing for AI models. Also, working in many research that focus on Artificial intelligent – Cyber security and social media mining for building smart detection system that identify cybercriminal accounts to improve security on Social media.

Specialization: Cyber Security – Artificial Intelligent – Big Data – Social media Mining - Data Scientist

Assistant Professor, Department of Biochemistry, Faculty of Sciences, King Abdulaziz University

Dr Asseri was born on the 5th of May 1981 in Mahayl, Saudia Arabia. After finishing secondary education, he started his study in biochemistry at the Faculty of Science at King Abdulaziz University in Jeddah and graduated in 2004 with a Bachelor's degree. After graduation, he worked as a medical lab technician in the Saudi German Hospital in Jeddah for two years. From 2007 until 2013, he worked as an academic technician at King Abdulaziz University. During that period, he obtained his master's degree (2011), in technical anatomy and histology. He has published two scientific books and other scientific papers in the field of histology and biochemistry. In 2013 he became a lecturer in the Biochemistry Department – Faculty of Science at King Abdulaziz University. In the period between 2016-2020, he started a Ph.D. journey on Medical Biochemistry at the Department of Molecular Cell Biology at Vrije Universiteit Amsterdam, under the supervision of Dr. Dirk Bald and Prof. Holger Lill. Asseri’s project at VU Amsterdam was embedded within the Amsterdam Institute of Molecular and Life Sciences (AIMMS), a research center that uniquely joins Molecular and Life Sciences and aims at the elucidation of molecular mechanisms of diseases and the development of novel therapeutics. There, his studies mainly focused on the biochemical characterization of bacterial membrane proteins and their role as novel drug targets. During his Ph.D., he was involved in a research collaboration with the Membrane Bioenergetics Group at Delft University of Technology (a top technology university in the Netherlands) headed by Dr. Duncan McMillan. After obtaining his Ph. D., Asseri returned to Saudi Arabia to start his career as an assistant professor and researcher at King Abdulaziz University,Faculty of Science, Biochemistry department.

Dr. Majed Felemban is an Assistant Professor in Medical Laboratory Technology Department, Faculty of Applied Medical Sciences, King Abdulaziz University and is a Lead Researcher in Stem Cell Sciences.

He received his MSc degree in Biotechnology from Queensland University of Technology, Australia and his PhD from Newcastle University, UK where he was trained under the supervision of a highly cited scientist in stem cell research, Professor Majlinda Lako.

Dr. Majed research focuses on reprograming human somatic cells such as skin fibroblast into human induced pluripotent stem cells (hiPSCs) and differentiate them into specific human tissues and organoids such as retinal, pancreatic and cardiomyocyte tissue, to model genetic disorders and help to improve the development of regenerative medicine.

Fatemah O. Kamel is an Associate Professor of Clinical Pharmacology in Faculty of Medicine at King Abdulaziz University (KAU), and appointed as department supervisor since 2017. A part-time faculty member at the Medical education department at KAU since 2019. Head of Mini Multiple Interviews (MMI) for student admission and member at Quality and Accreditation Unit, student support unit and neuroscience unit since 2019 in the Faculty of Medicine, KAU, Jeddah, Saudi Arabia.

She is a graduate of KAU Medical School, Jeddah, Saudi Arabia. She completed her Master’s degree in Pharmacology from Kings College, London, UK. Also, she has completed a second master degree in medical education from KAU in collaboration with University of Illinois, Chicago, USA. She has been awarded PhD degree from Faculty of Medicine, Imperial college, London, UK.

She published a total of 20 research articles in ISI journals. She has supervised a total of 10 masters students at the department of Pharmacology at KAU. Currently a principal investigator for a project entitled hematological parameters as therapeutic targets for COVID-19 patients: using artificial intelligence.

She is seeking an opportunity for enormous success in Clinical Pharmacology and medical education by stimulating her mind in a fascinating field in which she is highly motivated to prosper. She enthusiastically foresees the opportunity to be able to combine her motivated personality to embark on academic career and so have a major impact on academia and clinical research.

Mustafa Zeyadi

Associate Professor in Biotechnology

Biochemistry department

My interesting Microbiology-Chromatography-Inorganic Biochemistry-Bioinformatics

Supervisor of scholarship management

King Abdulaziz University

I completed my PhD degree in Department of Molecular Biology and Biotechnology at the University of Sheffield, United Kingdom. Currently I am an associate professor in Department of Biochemistry, Faculty of Science, KAU. The research project of my study focused on investigation of the dual roles of two citric acid cycle enzymes, aconitase A and B, as both metabolic catalysts and RNA-binding proteins that mediate a novel oxidative-stress responding and rapidly reacting, post-transcriptional mechanism of regulating gene expression. Currently I am working to collaborate with a research group interested in field of microbiomes of hosts and the environment and understanding the characteristics and spread of antimicrobial-resistant pathogens in the community & environment. Currently I am ruining with a team group a central lab concerning in microbial toxins & natural products analysis.

Some Thesis supervision

The research projects focused on a number of topics such as studying the effect of the gut microbiota of living organisms on the environment and society, the effect of environmental pollution on antibiotic resistance genes and the natural and toxic products, especially in isolating and examining bioactive compounds from herbal extracts.

Teaching activities

Metabolism

Metabolic regulation

Scientific methodology (postgraduate students)

Some readings in bioinformatics

I hold an assistant professor position in Molecular Genetics, Medical Laboratory Technology Department, Faculty of Applied Medical Sciences, KAU. I also work as a researcher in Princess Aljawhara Center of Excellence in Research of Hereditary Disorders (PACER-HD), and research laboratory supervisor. My research focus is characterizing the genetic basis of isolated and familial cases of cardiovascular diseases among Saudi families. Most of my published research aims at bridging the gap of the current understanding of single gene and or complex genetic diseases, enabling thereby the provision of further insights towards the screening of genetic disorders among the Saudi population. This will facilitate the delivery of proper public awareness regarding genetic disorders and how to minimize their occurrences to a great extent. My research will also help in the discovery of novel diagnostic and or therapeutic markers using computational biology tools followed by commercialization of research products

Dr. Faisal A. Alzahrani is an Associate Professor of Molecular Biology at King Abdulaziz University. He received his Ph.D. in Medical Sciences from North West Cancer Research Centre at Bangor University, where he studied the mechanisms of genome maintenance in cancer stem cells and stem cells. After that, he joined the university as a faculty member, set up his team and laboratory, and was appointed as deputy head of the stem cell unit. Dr. Alzahrani subsequently focused his research on stem cell-derived exosomes and their therapeutic applications. While working as a visiting lecturer at Aston Medical School in the UK, he became more interested in translating research and joined MirZyme Therapeutics. Currently, he works within a unique team that aims to develop precision treatments and AI tools for diagnostics of pregnancy disorders in general and preeclampsia in particular.

Dr. Abdelsattar Omar— Scientific Consultant for KAU’s Vice President for GSSR, Associate Professor of Medicinal Chemistry in the Pharmaceutical Chemistry Department at the Faculty of Pharmacy in King Abdul-Aziz University, Jeddah, Saudi Arabia.

Dr. Omar is the director of Drug Discovery and Development Research group. He is also a frequent participant in Medicinal Chemistry research projects sponsored by the Deanship of Scientific Research (DSR) at King Abdulaziz University and King Abdulaziz City for Science and Technology (KACST).

He has been working on several projects in drug discovery, with years of expertise and experience in organic synthesis, drug design, and molecular discovery. In addition to that, he is an expert synthetic organic chemist. He also has experience in computer-aided drug design and supervises the state-of-the-art Computer-Aided Drug Discovery Laboratory at King Abdulaziz University.

He has had many collaborations and research activities with international universities and has collaborated with some startup companies in the USA. He has also a record of more than 16 granted US patents. He has also participated in Egyptian Pharmaceutical companies in building strategic regulatory objectives to drive regulatory processes of an effective communication network.

Dr. Omar had a major and active role in the establishment and operation of the Bioequivalence Center in the Faculty of Pharmacy at Al-Azhar University, Egypt. He has a good practical and theoretical experience in bioequivalence study for the pharmaceutical dosage form, in-vitro pharmaceutical study, stability study for the pharmaceutical dosage form and analysis of raw materials.

is an Associate Professor of Statistics and Operations Research, Faculty of Science, King Abdulaziz University (KAU).

He is currently a Consultant for Vice President for Development, at KAU. In addition, Dr. Mahmoud is working in different research groups at many universities such as the Combinatorial Optimization and Graph Algorithms Group (COGA), Faculty II Mathematics and Natural Sciences, Berlin University of Technology, Berlin, Germany, the British University in Egypt BUE, Arbeitsgruppe Stochastik“,Christian Albrechts University at Kiel CAU Kiel, Germany. Moreover, he worked as a research assistant in department of Computer Science and Automation, Integrated Communication Systems Group, Ilmenau University of Technology TU Ilmenau, Thuerengen, Germany.

Dr. Mahmoud Ragab received his B. Sc. in Statistics and Computer Science from Mansoura University, Mansoura, Egypt and M. Sc. Degree in Statistics & operations Research, Faculty of Science, Al Azhar University, Cairo, Egypt. He obtained his Ph.D. degree in Partial Quicksort Algorithms and weighted branching Processes from the faculty of Mathematics and Natural Sciences of the Christian-Albrechts-University at Kiel (CAU), Schleswig-Holstein, Germany.

His research focuses on Sorting Algorithms / Efficiency, Optimization, Mathematical Modeling, Data Science / Data Analysis, Mathematical/Applied Statistics, Neural Networks, Time series Analysis, Quantum Computation

Dr. Mohammad Imran Khan is currently working as an Associate Professor in the Department of Biochemistry in Faculty of Science at King Abdulaziz University (KAU), Jeddah. He has obtained his Ph.D. in Biochemistry from Faculty of Medicine, Aligarh Muslim University (AMU) in association with CSIR-Indian Institute of Toxicology Research (IITR), India.

After finishing his Ph.D., he has completed his post-doctoral training from Department of Dermatology, University of Wisconsin, Madison USA. In 2016, he left USA to join King Abdullah University of Science and Technology (KAUST) in Bioscience and Bioengineering (BESE) division as senior researcher. In 2017, he moved to King Abdulaziz University as full-time faculty member to join the Department of Biochemistry in the Faculty of Science.

His lab is currently focused on cellular molecules and pathways that are connecting cellular metabolism with epigenome. He is also serving as research lead for the Core Metabolomics Facility in the Faculty of Science.

• Associate Professor of Microbiology and Molecular Biology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University.
• Consultant at Center of Alignment of Educational Outcomes with Labor Market (CAEOLM), Vice President for Development Offices, King Abdulaziz University.
• Visiting Scholar at Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology (KAUST).
• Phone: Mobile: (+966)544670435, (+20)1064767102, Home: (+20)222671595 Office: Ext. 6400000-22660. P.O. Box 80260, Jeddah 21589, KSA.
• Email: melfaky@kau.edu.sa
• Twitter: @elfaky_mahmoud
• LinkedIn: Mahmoud Elfaky, PhD
• ResearchGate: Mahmoud Elfaky
• Web of Science ResearcherID: D-6015-2015 https://publons.com/researcher/2422593/mahmoud-a-elfaky/
• Google Scholar https://scholar.google.com/citations?user=uinhXDcAAAAJ&hl=en

Dr Moustafa El-Araby obtained his PhD from the University at Buffalo, State University of New York, USA under supervision of Professors Wayne Anderson and Huw Davies in 2001. Before that he graduated from the Faculty of Pharmacy, Cairo University in 1985 (B. Pharm.) and Al-Azhar University in 1992 (M.Sc. Pharm. Chem.). After doing his post-doctoral with Professor David Hangauer at University at Buffalo, he joined the Drug Discovery at Johnson&Johnson Pharmaceutical Research and Development, New Jersey where he worked in with the combinatorial chemistry and automated synthesis team. In 2006, Dr El-Araby moved to academia as a lecturer of Pharmaceutical Organic Chemistry, Helwan University, Egypt. He joined the Faculty of Pharmacy at King Abdulaziz University in 2012.

Dr Moustafa El-Araby obtained his PhD from the University at Buffalo, State University of New York, USA under supervision of Professors Wayne Anderson and Huw Davies in 2001. Before that he graduated from the Faculty of Pharmacy, Cairo University in 1985 (B. Pharm.) and Al-Azhar University in 1992 (M.Sc. Pharm. Chem.). After doing his post-doctoral with Professor David Hangauer at University at Buffalo, he joined the Drug Discovery at Johnson&Johnson Pharmaceutical Research and Development, New Jersey where he worked in with the combinatorial chemistry and automated synthesis team. In 2006, Dr El-Araby moved to academia as a lecturer of Pharmaceutical Organic Chemistry, Helwan University, Egypt. He joined the Faculty of Pharmacy at King Abdulaziz University in 2012.

Current Research Interest:

• Designing interfering molecular probes against small-peptide vital to the growth of pathogenic viruses such as Flaviviridae and Corona families.
• Sickle-cell disease: Development of advanced compounds preclinically to establish IND status in collaboration with US scientists and a Biotechnology firm (Illexcor L.L.C.). Establish a pipeline for the discovery of new treatments. Currently we are optimizing compounds to enter clinical trials.
• Anticancer lead optimization: We aim to optimize pharmacological profiles focusing on difficult issues such as efficacy against resistant tumors and tumoral pharmacokinetics.

Hisham Altayeb

Haneen Banjar is an assistant professor, computer science department, faculty of computing and information technology at King Abdulaziz University.

Dr. Banjar received her PhD in Bioinformatics from the University of Adelaide ( 2018). She also received the Alumni Award from The Australian ambassador. In addition, she received the honorary certificate from the Saudi Arabian Cultural Mission for her publications in the National Centre for Biotechnology Information (NCBI) database and multiple publications in ISI journals.

Haneen’s research focuses on artificial intelligence (AI) in medicine. She has multidisciplinary research with several research centers. Collaboration with King Fahad Center for Medical Research, Hematology Research Group, the research explores AI in hematologic diseases. Collaboration with the Center of Excellence in Genomic Medicine Research, the research explores an intelligent system for COVID 19 treatment management. She also has a collaboration with the South Australian Health and Medical Research Institute (SAHMRI) in Adelaide, King Faisal Specialist Hospital and Research Centre in Riyadh, and King Abdulaziz Medical City in Jeddah. The research explores a personalized medicine support system for chronic myeloid leukemia patients.

Diena Mohammedallam Almasri

I was awarded a Doctor of Philosophy (PhD) in in Cellular and Molecular Biology (2010) from Strasbourg University, France. I worked as a post-doctoral fellow in Laboratory of Biophotonics and Pharmacology CNRS UMR 7213 and as an assistant Professor at the Faculty of Pharmacy, Strasbourg University, France. Actually, I am working as an associate Professor at Biochemistry Department, Faculty of Sciences, King Abdulaziz University, KSA. My research topic focuses on elucidating the cellular and molecular mechanisms of cancer cell signaling and gene regulation. In particular, I am deeply interested in defining epigenetic molecular mechanisms by which cancer cells inherit their carcinogenic signature to daughter cells during cell division. My work was published in top journals including Oncogene, Journal of Experimental & Clinical Cancer Research, Biochemical pharmacology, European journal of cancer, Cellular signalling, Genes, Oncotarget, Investigational new drugs., etc. I am an editorial board member of journals: Oncology Letters, Molecular of Medicine Reports and Epigenetic Insights.

Dr. Alganmi is Deputy Director for the Center of Excellence in Genomic Medicine Research (CEGMR). She works as an assistant professor at the faculty of computing and information technology. Also, she leads the bioinformatics unit and data center in the Center of Excellence in Genomic Medicine Research (CEGMR) at King AbdulAziz University. She received her Ph.D. from the University of Surrey, UK in computational genomics. During her doctoral studies, she joined The Surrey Sleep Research Centre (SSRC) where she analyzed and applied machine learning on two large clinical studies that showed how chronic and acute insufficient sleep and mistimed sleep disrupt 24h gene expression profiles in the human blood transcriptome. Dr. Alganmi, established the first genomics data center in KAU, developed Next generation sequencing pipeline to analyze clinical data and perform many research activities such as Cohort Studies and Functional Characterization of Genetic Variants.

Aliaa Alamoudi, MBBS, PhD, is an Assistant Professor of Cancer Biology in the Department of Clinical Biochemistry at King Abdulaziz University (KAU), and head of the female department.

She is currently the head of the Regenerative Medicine and Stem Cell Unit at the King Fahd Centre for Medical Research in King Abdulaziz University and a member of the Saudi Diabetic Research group. Dr Alamoudi obtained her Dphil in Clinical Pharmacology from the department of Oncology, University of Oxford, where she worked in gene therapy in tumour immunology, and recombinant viral vaccines in cancer therapeutics. Currently, her research interests focus on cancer metabolomics and proteomics. She is part of the cancer therapeutics sub-group of the Regenerative Medicine Unit with interest in natural drugs such as, thymoqunione, and its chemomodulatory effects and role on cancer stem cells population, tumour metabolism, and the molecular clock machinery. She is a principle investigator and/or a co-investigator of four ongoing research grants.

Dr Alamoudi has also lectured and supervised a number of postgraduate students, and has obtained a Master’s Degree in Medical Education in collaboration with the University of Illinois of Chicago and is a member of the curriculum committee board in the Faculty of Medicine, KAU.

Current position:

• Assistant Professor at Department of medicine, Division of Endocrinology and metabolism since Nov 2019.
• Internal medicine consultant (SCFHS)
• Endocrinology and metabolism consultant (SCFHS)
• Inpatient Director at KAUH since November 2020
• Team leader for Quality Improvement & Accreditation teams at KAUH

Certifications:

• The American Board of Internal Medicine, ABIM (2017)
• The Royal college of physicians and surgeons of Canada specialist certificate in Internal Medicine (September 2017)
• The Royal college of physicians and surgeons of Canada specialist certificate in Endocrinology and Metabolism (September 2018)
• Clinical Pituitary Fellowship (2019)

Mr. Samer Alamoudi, Master degree in microbiology, faculty of Science, King Abdulaziz University, my research interests are in the field of molecular studies of microbiology, Human Microbiome Research, Antimicrobial Resistance, gene mutations and their effect on metabolic processes and genetic engineering in microorganisms.

Dr. Hatem R. Besbes, Department of Physics, Faculty of Sciences, King Abdulaziz University Hatem R. Besbes received the B.S. in physics from Sfax University in 1992, the M.S. degrees and Ph.D. in physics from Tunis El Manar University in 1995 and 2004, respectively, and the habilitation in Biophysics from Tunis El Manar University in 2016. He is currently Professor in Biophysics at Faculty of Medicine, Tunis El Manar University and Associate Professor in medical physics at the Department of physics, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. His research interests include Artificial intelligence in medical imaging, medical imaging instrumentation, processing, and quality control, physiological signals, and biosensors.

Dr. Reem Alsolami is a medical scientist and professor assistant in haematology, medical laboratory science department. She has solid experience in next generation sequencing technologies including whole genome and targeted approaches. During the DPhil study at University of Oxford she had the chance to work at highly specialized molecular diagnostic laboratory at Oxford University Hospital under NHS honorary contract. Her core skills include experimental design, pipeline validation, troubleshooting, bioinformatics and statistical data analysis. Dr Alsolami has an analytical and investigative experience in cancer characterization and mutations profiling which has enabled her to publish in high impact journals. She has demonstrated an ability to manage a laboratory project and communicate with a wide variety of scientific colleagues and maintained active international collaboration.

Dr. Heba Alkhatabi is an Associate professor in the department of medical laboratory science, faculty of applied medical school in King Abdulaziz University. Also, she is a research associate in different center and unit as: Center of excellence in genomic Medicine research (CEGMR), and Hematology research unite at king Fahad research center (HRU).

Dr. Alkhatabi, obtained a doctoral degree in: “microRNAs implications in hematological disorders” in the Department of Hematological Medicine, Cancer Division, at King’s College London, UK. Under the supervision of Professor Ghulam Mufti, she has witnessed exceptional career development and made extraordinary strides. She worked on her own using advanced technique, in addition to extensive involvement in several side researches. She represented her department and college at one of the prestigious international conferences, American Society of Hematology (ASH) conference in USA in 2012 and 2014.

In 2017 she was appointed as a laboratory Manager at Genati lab then Roya Lab in 2018. During that time, she proved herself very capable as a leader through the many roles she played during the past period. Those roles included raising the bar for the organizational standard that Roya lab wanted to follow as a practical branch for the university that is providing heavy technical, clinical and research services. During this period, she interacted with people at various levels (e. g. employees, students, customers and partners).

Dr. Alkhatabi, PhD experience by working in both research and diagnostic labs gives her interpersonal skills and exceptional work ethics along with the other characteristics of dedications allowed her as a Laboratory Manager to be involved with ongoing diagnostic laboratory work and research management procedures that are equipping her with problem solving, test improvements and implementations of new assays that serve both diagnostic and research services and other relevant competencies.

As associate professor, Dr. Alkhatabi involved in mentoring and supervising several undergraduate and post-graduate students She provides support for students on fieldwork, clinical training, or research project, as required. Ensures that student feedback on teaching is sought through questionnaires and other sources and to respond constructively to such feedback. Makes a full active research contribution, both individually and in collaboration with others, with the highest possible rating in the Research Excellence. Her main interest is cancer research and she awarded different grants to fund projects in genomic application in hematological malignancies and colorectal cancer. Her experiences in the molecular genetic field allowed her to participate in many research and that contribution was ended with more than 35 publications.

Naif Abdullah R. ALMALKI is an academician specializing in Nutritional Epigenetics. His PhD was done in the HAMICHE team in the Institut de génétique et de biologie moléculaire et cellulaire (IGBMC), a research center affiliated to University of Strasbourg, France, under supervision of Christian BRONNER and Ali HAMICHE. Dr. ALMALKI was scholarshiped at the beginning of 2017 to France as a Learner of the French language for one year at the Languages institute Stralang affiliated with Campus France in Strasbourg before he joined the HAMICHE team as a Doctorate Researcher in 2019 for three years and a half, as an extension of the Master and Bachelor degrees in Biochemistry where they have done in the Biochemistry department, Faculty of Sciences, King Abdulaziz university. Dr. ALMALKI graduated academically as a teaching assistant, passing to Lecturer until he got an assistant professor currently. Dr. ALMALKI is affiliated with the Center for artificial intelligence in Precision Medicine and the Experimental Biochemistry unit, King Fahad medical research Centre at King Abdulaziz university.

Dr. Arkook is currently an Assistant Professor in the Department of Physics at King Abdulaziz University. He was awarded his Ph.D. in Physics from the University of California, Riverside, in the United States, in 2020. He mainly worked as an experimental condensed matter physicist with broad interests in device fabrication, biosensors, materials analysis, and characterization. Before graduating, he served his internship during the summer of 2019 at a startup company named Cellular Nanomed Inc. at the Applied Innovation at the University of California, Irvine, USA, working as a researcher developing magnetoelectric nanoparticles for drug delivery and brain-computer interfaces. The company's investigation was explicitly focused on next-generation nonsurgical neurotechnology. In 2010, King Abdulaziz City for Science and Technology (KACST) funded his MSc thesis under the Graduate Research Program. Dr. Arkook has a membership of the American Physical Society (APS) and Society of Photo-Optical Instrumentation Engineers (SPIE).

Tahani A. Bakhsh is an Assistant Professor of Molecular Genetics at the University of Jeddah. Her Ph.D. is in Genetics from King Abdulaziz University and her Master is in Biotechnology with distinction from the University of Wollongong, Australia. She gains the First-place award and golden prize in the Thirteen Forum for King Abdulaziz University Students in 2022 and participated as a Ph.D. student in the Artificial Intelligence for Precision Medicine (Drug Discovery Program 2022). During her study, she was working on cancer genetics, focusing on RNA interference mechanisms, especially the processes through which microRNAs are generated and released, and the associations of microRNA in the identification and diagnosis of colorectal cancer by using next-generation sequencing (NGS).

Her research interests include high-throughput multi-omics data analysis and the use of artificial intelligence to evaluate multi-omics data to discover novel biomarkers and therapeutic targets for cancer illnesses. Her objective is eager to expand her skills and knowledge via scientific research in order to support the community in improving healthcare, the economy, and lifestyle through creativity and innovation.

Dr. Varish Ahmad has a B.Pharm, M.Tech in Biotechnology with a specialty in Bioprocess Engineering, and Ph.D in Microbial Biotechnology. He is currently faculty at King Abdullaziz University-The Applied College-Health Information Technology Department. He has made outstanding contributions in the fields of microbiology and food technology. He has more than ten years of teaching experience at the graduate and post-graduate levels. During the last 5 years of his research career, he has published more than 35 research papers, including reviews and book chapters, in reputed international journals and distinguished himself as a renowned food microbiologist. His major areas of research interest at present are the screening of some beneficial microbes from natural resources and food sources and the therapeutic molecules derived from them. He has several research grants, including ones for petroleum degradation or desulfurization mediated by microbes, natural food preservative development, and therapeutic lactobacilli.

Jenny Jeehan Nasr is an American professor and head of the Pharmaceutical Analytical Chemistry Department in Faculty of Pharmacy, Mansoura University, Egypt. She is a member of the American Chemical Society (ACS) . She is also a member in the UNESCO Bioethics Network concerned with Women's Issues in the Arab Region. She was a former member of the National Committee for Women in Science of the Academy of Scientific Research and Technology, Ministry of Higher Education and Scientific Research, Egypt. In addition, she was a former fellow of L'Oreal-UNESCO for Women in Science Pan Arab Regional Programme. She had achieved her Ph.D. degree in September 2009. Her research focuses on analysis of drugs in formulations and biological fluids in addition to stability studies of drug raw materials. She has prominent contribution in the field of analysis of drug residues in foods in order to serve the community through avoiding risks to human health. She has performed previous research to determine anti-cancer drug traces in wastewater. She has a leading role in green chemistry being a facilitator in the initiative of the Center for Green Chemistry & Green Engineering, Yale University in collaboration with UNIDO to promote green chemistry around the world. Her current research focuses on employment of Artificial Intelligence (AI) and machine learning (ML) as supportive routine tools to solve medical and environmental problems in addition to utilization of green chemistry to face climate changes and set applicable solutions to major current challenges

Hamzah Hassnein A. Ahmed is currently an assistant professor at the Department of Radiologic Sciences. Dr. Ahmed has graduated from King Abdulaziz University in 2008 with a Bachelor of Sciences degree in diagnostic radiology. After completing his internship year in 2009, working as a nuclear medicine technologist at King Abdulaziz University Hospital, he has gotten a teaching assistant position that grants him a scholarship to continue his graduate education in the United States of America. He has earned a Master of Sciences degree in radiologic and medical imaging sciences with PET/CT track in 2014 from Thomas Jefferson University, Philadelphia, PA. During his studies in the US, Dr. Ahmed has trained and worked in different hospitals in the greater Philadelphia region. He has received a travel award and the Best Student Poster Award at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI-TS 61st) in St. Louis, Missouri.

Dr. Ahmed has continued his doctoral studies after three years of supporting his family while his wife, Dr. Abudawood, is studying for her doctoral degree in nursing at the University of Florida. As Dr. Ahmed transitions to graduate research at the University of Florida, his interest has shifted from molecular imaging to physiology and pathophysiology. Joining the laboratory of Dr. Timothy J. Garrett, Dr. Ahmed has started research on the role of Fusobacterium spp. in colonic epithelial and colorectal cancer cell metabolism. His study shows that Fusobacterium spp. can alter the metabolism of these cells. He has presented this work at several national and local scientific meetings within the United States. Detecting a significant metabolic or lipid biomarker will allow this research to extend to molecular imaging and clinical translation. Upon his successful dissertation defense, Dr. Ahmed has graduated with a Doctor of Philosophy in Medical Sciences from the University of Florida in 2021.

Faisal M. Alshref is an academic faculty at the Department of Biochemistry and the chairman of Saudi in Oxford Research Symposium (SORS).

Mr. Alshref holds a bachelor degree in Biomedical Science and Chemistry from University of Maryville – Saint Louis (USA). His academic journey continued as he obtained his master degree in Molecular Biology from University of Queensland – Australia. Mr. Alshref is currently a Doctor of Philosophy student at University of Oxford – UK with a research interest in bacterial physiology, structural biology and antimicrobial resistance.

Mr. Alshref has been a member of regional and multinational collaborations throughout his academic journey in the United States of America, Australia and the United Kingdom. His expedition in combating AMR is multidisciplinary as it involves different sectors and stakeholders such as: University of Oxford, University of Queensland, King Saud Bin Abdul-Aziz University for Health Sciences, Ministry of Environment, Water and Agriculture and King Abdullah International Medical Center.   

As part of his commitment, Mr. Alshref has represented the Saudi Arabian students association in USA, Australia and UK. He is currently the public relations officer of Saudi students association in Oxford.